Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Harbinger Health CEO Stephen Hahn On Early Cancer Detection To ‘Move The Needle’ On Survival

Mar 15 2023

• By Marion Webb

SXSW 2023 — • Source: Medtech Insight

Related Content

'All Options On The Table,' Says Hillebrenner On Diagnostics Reform

Feb 23 2023

Biden Shouts Out ‘Cancer Moonshot’ In State Of The Union

Feb 08 2023

So The Public Health Emergency Is Over. Now What?

Feb 28 2023

FDA Draft Guidance Takes Aim At Racial, Ethnic Disparities In Clinical Trials

Apr 13 2022

Liquid Biopsy Revolutionizing Cancer Care, But Costs Continue To Inhibit Global Potential

Sep 29 2022

HLTH 2022 Roundup: Mirvie, Grail, Biofourmis, Komodo Health, Babson Diagnostics

Nov 18 2022

Top 100 Outlook 2021: Medtechs Look To Build On Experiences Of Serving Global Markets In A Pandemic

Dec 04 2020

Related Companies

Moderna, Inc.

Tessera Therapeutics

Generate:Biomedicines

Thrive Bioscience Inc.

Exact Sciences Corp.

Additional Topics

Artificial Intelligence Business Strategies Clinical Trials Commercial Coronavirus COVID-19 FDA Innovation Research & Development Strategy Vaccines Exec Chats Cancer In Vitro Diagnostics Diagnostics Medical Device

More from Oncology

More from Device Area

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window